Firstcall Research is bullish on Biocon and has recommended buy rating on the stock with a target of Rs 430 in its April 11, 2011 research report.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!